1050, chemin Sainte-Foy
K2-13
Québec, Québec
Canada G1S 4L8
Dernières nouvelles
- [ULaval Nouvelles] Découvertes fortuites lors de tests génomiques: au patient de choisir 2021-03-23
- [Ulaval Nouvelles] Cancer du sein: les Canadiennes appuient fortement le dépistage adapté au risque personnel 2021-02-16
- Étude clinique sur le dépistage personnalisé du cancer du sein : 4 000 femmes recherchées 2020-08-18
Cross-Cultural Adaptation and Validation of a French Version of the Genetic Counseling Satisfaction Scale (GCSS) as an Outcome Measure of Genetic Counseling for Hereditary Breast and Ovarian Cancer
Article de revueHealthcare (Basel), 9 (9), 2021.
Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I)
Article de revueJ Pers Med, 11 (6), 2021.
Survey of palliative care providers' needs, perceived roles, and ethical concerns about addressing cancer family history at the end of life
Article de revuePalliat Support Care, 19 (2), 2021.
A Collaborative Model to Implement Flexible, Accessible and Efficient Oncogenetic Services for Hereditary Breast and Ovarian Cancer: The C-MOnGene Study
Article de revueCancers (Basel), 13 (11), 2021.
Women's Views on Multifactorial Breast Cancer Risk Assessment and Risk-Stratified Screening: A Population-Based Survey from Four Provinces in Canada
Article de revueJ Pers Med, 11 (2), 2021.
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Article de revueNat Genet, 52 (1), 2020.
Survey of primary care physicians' views about breast and ovarian cancer screening for true BRCA1/2 non-carriers
Article de revueJ Community Genet, 11 (2), 2020.
What do cancer patients' relatives think about addressing cancer family history and performing genetic testing in palliative care?
Article de revueEur J Hum Genet, 28 (2), 2020.
Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study
Article de revueJ Natl Cancer Inst, 111 (4), 2019.
Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers
Article de revueBr J Cancer, 121 (2), 2019.
Projets actifs
- Personalized Risk Assesment for Prevention and Early Detection of Breast Cancer : Integration and Implementation (PERSPECTIVE II), du 2017-11-01 au 2025-09-30
- Personalized risk-stratified breast cancer follow-up care: a feasibility and acceptability study, du 2023-06-26 au 2026-06-30
- What are my options? A feasibility study of a personalized primary prevention strategy for women and men at high risk of breast and prostate cancer, du 2022-01-15 au 2025-03-31